Niazi T, Saad F, Tisseverasinghe S, Koul R, et al. Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 2025;26:1158-1167.
PMID: 40907514